Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Actelis Networks | ASNS | Nov 29, 2024 | 1.23 | -3.15 |
Actinium Pharmaceuticals | ATNM | Nov 29, 2024 | 1.44 | 0.00 |
Active Bear ETF | HDGE | Nov 29, 2024 | 16.87 | -0.47 |
Active U.S. Real Estate Powershares | PSR | Nov 29, 2024 | 99.02 | -0.53 |
Actuate Therapeutics | ACTU | Nov 29, 2024 | 8.13 | -6.34 |
Acuity Brands | AYI | Nov 29, 2024 | 320.69 | +0.17 |
Acumen Pharmaceuticals | ABOS | Nov 29, 2024 | 2.27 | +0.44 |
Acurx Pharmaceuticals | ACXP | Nov 29, 2024 | 1.25 | +9.17 |
Acushnet | GOLF | Nov 29, 2024 | 73.11 | +0.26 |
ACV Auctions A | ACVA | Nov 29, 2024 | 22.62 | -0.40 |
ACWI Ex-US Index MSCI Ishares | ACWX | Nov 29, 2024 | 54.41 | +0.89 |
ACWI Index MSCI Ishares | ACWI | Nov 29, 2024 | 121.77 | +0.68 |
Adagene ADR | ADAG | Nov 29, 2024 | 2.34 | +1.08 |
Adagio Medical | ADGM | Nov 29, 2024 | 2.67 | +4.71 |
Adams Diversified Equity Fund | ADX | Nov 29, 2024 | 20.57 | +0.98 |
Adams Natural Resources Fund | PEO | Nov 29, 2024 | 23.68 | +0.38 |
Adams Resources & Energy | AE | Nov 29, 2024 | 37.22 | -0.05 |
AdaptHealth | AHCO | Nov 29, 2024 | 10.03 | +0.40 |
Adaptimmune Therapeutics ADR | ADAP | Nov 29, 2024 | 0.72 | -0.59 |
Adaptive Biotechnologies | ADPT | Nov 29, 2024 | 5.94 | +3.66 |
ADC Therapeutics SA | ADCT | Nov 29, 2024 | 2.42 | +7.08 |
Addentax Group | ATXG | Nov 29, 2024 | 0.56 | +2.96 |
Addex Therapeutics ADR | ADXN | Nov 29, 2024 | 8.71 | +1.00 |
Addus HomeCare | ADUS | Nov 29, 2024 | 122.84 | +1.28 |
Adecoagro | AGRO | Nov 29, 2024 | 10.90 | +1.40 |
Adeia | ADEA | Nov 29, 2024 | 12.12 | +0.66 |
Adial Pharmaceuticals | ADIL | Nov 29, 2024 | 1.00 | +0.91 |
Adicet Bio | ACET | Nov 29, 2024 | 1.13 | +1.80 |
Adient | ADNT | Nov 29, 2024 | 19.23 | -0.16 |
Aditxt | ADTX | Nov 29, 2024 | 0.37 | +6.17 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.